Design and Optimization of Pharmaceutical Gels (2nd Edition)

A special issue of Gels (ISSN 2310-2861). This special issue belongs to the section "Gel Applications".

Deadline for manuscript submissions: 30 July 2024 | Viewed by 450

Special Issue Editors


E-Mail Website
Guest Editor
College of Pharmacy, Jinan University, Guangzhou 510632, China
Interests: inhalable nanomedicines; drug delivery; ferroptosis; protein corona; biological fate
Special Issues, Collections and Topics in MDPI journals
College of Pharmacy, Jinan University, Guangzhou 510632, China
Interests: nanoparticles for pulmonary drug delivery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
College of Pharmacy, Jinan University, Guangzhou 510632, China
Interests: drug delivery; pulmonary drug delivery system; nose–brain drug delivery system
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are grateful to all authors, reviewers, and readers for their responses to the first edition of “Design and Optimization of Pharmaceutical Gels”. You can access these articles at no cost via the following link:

https://www.mdpi.com/journal/gels/special_issues/Y22NN1L4RC

The efficacy of many bioactive agents, including drugs, food supplements, and vaccines, is limited because of their poor chemical stability, low water solubility, and low oral bioavailability. Thus, delivery vehicles are being developed to overcome these problems. Because of their high drug loading efficiency, high biocompatibility, and low toxicity, gels in particular have attracted much attention in the field of drug delivery systems (DDSs), such as sustained-release DDSs, controlled-release DDSs, targeting DDSs, and local DDSs.

Gels are three-dimensional, semi-solid systems consisting of polymeric matrices. The physicochemical properties of gels, such as their physical strength, viscosity, and self-healing ability, can be tailored to meet the specific requirements of applications in various fields, such as drug and cell delivery, bioscaffolds, and the modelling of extracellular matrices. In particular, novel gel-based delivery systems (such as intelligent hydrogels, in situ gels, emulsion gels, nanogels, vesicular gels, and microgels) can release drugs through specific biological or external stimuli, such as temperature, pH, enzymes, ultrasound, antigens, etc., to achieve precise and local drug delivery. Therefore, gels have broad clinical application prospects and are anticipated to provide new, effective, and robust strategies for the theranostics of diseases.

The aim of this Special Issue is to shed light on the application of gels in material development, system construction, structural characterization, and disease. Research on gels with high translational potential is particularly sought after. Original research, reviews, mini-reviews, and perspective papers which reflect the status quo of this topic are warmly welcomed.

Dr. Zhengwei Huang
Dr. Ying Huang
Dr. Xuanjuan Zhang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gels is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gelation materials
  • novel gel-based delivery systems
  • intelligent hydrogels
  • in situ gels
  • emulsion gels
  • nanogels
  • vesicular gels
  • microgels

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 19863 KiB  
Article
Enhancing Effector Jurkat Cell Activity and Increasing Cytotoxicity against A549 Cells Using Nivolumab as an Anti-PD-1 Agent Loaded on Gelatin Nanoparticles
by Dalia S. Ali, Heba A. Gad and Rania M. Hathout
Gels 2024, 10(6), 352; https://doi.org/10.3390/gels10060352 - 21 May 2024
Viewed by 284
Abstract
The current research investigated the use of gelatin nanoparticles (GNPs) for enhancing the cytotoxic effects of nivolumab, an immune checkpoint inhibitor. The unique feature of GNPs is their biocompatibility and functionalization potential, improving the delivery and the efficacy of immunotherapeutic drugs with fewer [...] Read more.
The current research investigated the use of gelatin nanoparticles (GNPs) for enhancing the cytotoxic effects of nivolumab, an immune checkpoint inhibitor. The unique feature of GNPs is their biocompatibility and functionalization potential, improving the delivery and the efficacy of immunotherapeutic drugs with fewer side effects compared to traditional treatments. This exploration of GNPs represents an innovative direction in the advancement of nanomedicine in oncology. Nivolumab-loaded GNPs were prepared and characterized. The optimum formulation had a particle size of 191.9 ± 0.67 nm, a polydispersity index of 0.027 ± 0.02, and drug entrapment of 54.67 ± 3.51%. A co-culture experiment involving A549 target cells and effector Jurkat cells treated with free nivolumab solution, and nivolumab-loaded GNPs, demonstrated that the latter had significant improvements in inhibition rate by scoring 87.88 ± 2.47% for drug-loaded GNPs against 60.53 ± 3.96% for the free nivolumab solution. The nivolumab-loaded GNPs had a lower IC50 value, of 0.41 ± 0.01 µM, compared to free nivolumab solution (1.22 ± 0.37 µM) at 72 h. The results indicate that administering nivolumab-loaded GNPs augmented the cytotoxicity against A549 cells by enhancing effector Jurkat cell activity compared to nivolumab solution treatment. Full article
(This article belongs to the Special Issue Design and Optimization of Pharmaceutical Gels (2nd Edition))
Show Figures

Figure 1

Back to TopTop